<DOC>
	<DOCNO>NCT02366104</DOCNO>
	<brief_summary>BSHA cohort study healthy elderly enrol voluntarily . It ongoing since December 2008 . And purpose study assess clinical biological marker cardiovascular risk elderly participant .</brief_summary>
	<brief_title>Brasília Study Healthy Aging</brief_title>
	<detailed_description>Non-institutionalized outpatient preventive care voluntarily enrol study . Participants age 80 year , never manifest myocardial infarction , stroke peripheral arterial disease . Enrolled participant underwent detailed clinical examination , include assessment anthropometric measure , quality life WHOQOL-BREF , psychological test Geriatric Depression Scale ( GDS ) cognitive function mini-mental state examination ( MMSE ) . After 12h overnight fasting , study participant underwent blood sample collection biochemical analysis freeze plasma , serum DNA . Immediately blood collection , participant underwent cardiovascular ultrasound evaluation compute tomography ( CT ) scan week follow initial assessment . After baseline measurement , participant refer study outpatient clinic prospective medical follow-up evaluation . Anthropometric measure : body weight , height , waist circumference skinfold thickness ( triceps , biceps , suprailiac subscapular ) measure . Body mass index ( BMI ) calculate . Skinfold thickness mean triplicate measurement right side , use skinfold caliper ( WCS Plus® , Cardiomed , Curitiba , Brazil ) . Biochemical analysis : After collection , EDTA blood centrifuge 5 ◦ C , 4500 rpm 15min separate plasma carry follow measurement : glucose ( Glucose GOD-PAP , Roche Diagnostics , Mannheim , USA ) , total cholesterol ( CHOD-PAP , Roche Diagnostics , Mannheim , USA ) , triglyceride ( GPO-PAP , Roche Diagnostics , Mannheim , USA ) , HDL-C ( HDL cholesterol without pretreatment , Roche Diagnostics , Mannheim , USA ) , C-reactive protein ( highly sensitive , CardioPhase , Dade Behring , Marburg , USA ) , urea creatinine ( GLDH , Hitachi , Tokyo , Japan ) , fibrinogen ( Sysmex CA 1500 , Siemens , Munich , Germany ) , interleukin ( IL ) 10 tumor necrosis factor type alpha ( TNF-alpha ) ( eBioscience , San Diego , CA , USA ) . Parathyroid hormone ( PTH ) calcitonin ( Immulite 2000 , Siemens , Los Angeles , CA , USA ) , bone fraction alkaline phosphatase ( Hitachi Autoanalyzer , Tokyo Japan ) , calcium ( Hitachi Autoanalyzer , Tokyo , Japan ) , apoA apoB ( Behring Nephelometer BNII , Dade Behring , Marburg , Germany ) also measure . Carotid ultrasound : The evaluation intima-media thickness ( IMT ) presence carotid plaque assess use high-resolution B-mode ultrasound ( Philips , model IE 33 , 3-9 MHz linear transducer , Philips Medical Systems , Andover , MA , USA ) accord protocols American Association Echocardiography . Bilateral measurement make posterior wall bulb common carotid artery internal carotid artery program automatic edge detection ( QLAB version 6.0 software ) . Carotid plaque define presence focal thicken least 50 % high surround area focal region IMT &gt; 1.5 mm distinct adjacent edge . Cardiac compute tomography : Computed tomography perform 64-slice scanner ( Aquillion 64 , Toshiba , Ottawara , Japan ) . Axial slice 3 mm thickness 3 mm table-feed acquire 70 % R-R interval prospective ECG triggering . Coronary artery calcification define minimum 3 contiguous pixel peak Hounsfield unit density &gt; 130 . Coronary artery calcification score certified radiologist . The Agatston score use express value CAC .</detailed_description>
	<criteria>Aged 80 year Manifested atherosclerotic disease ( MI , stroke peripheral arterial disease ) accord medical evaluation , electrocardiogram echocardiogram Functional dependence institutionalization Cognitive impairment assess minimental state examination ( &lt; 13 point ) Use antiinflammatory last 30 day Current previous diagnosis neoplastic immune inflammatory disease Chronic obstructive pulmonary disease Glomerular filtration rate &lt; 25 mL/min/1.73 m2 Hepatic disease ( ALT AST ≥ 1.5 upper reference limit ) Chronic infectious disease ( ≥ 3 month ) Left ventricular ejection fraction &lt; 50 % echocardiography Manifested neoplasia admission first year enrollment</criteria>
	<gender>All</gender>
	<minimum_age>80 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Cardiovascular Diseases</keyword>
	<keyword>Aged</keyword>
	<keyword>Primary Prevention</keyword>
</DOC>